Leonteq Securities AG Increases Stock Position in Inspire Medical Systems, Inc. $INSP

Leonteq Securities AG boosted its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 187.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,812 shares of the company’s stock after purchasing an additional 14,873 shares during the period. Leonteq Securities AG’s holdings in Inspire Medical Systems were worth $1,177,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in INSP. Xponance Inc. lifted its holdings in Inspire Medical Systems by 2.9% in the 3rd quarter. Xponance Inc. now owns 4,177 shares of the company’s stock worth $310,000 after buying an additional 116 shares in the last quarter. Daiwa Securities Group Inc. boosted its position in Inspire Medical Systems by 38.7% in the 2nd quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock valued at $60,000 after buying an additional 130 shares during the last quarter. State of Wyoming grew its stake in shares of Inspire Medical Systems by 31.5% during the fourth quarter. State of Wyoming now owns 731 shares of the company’s stock valued at $67,000 after acquiring an additional 175 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Inspire Medical Systems by 84.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock valued at $42,000 after acquiring an additional 205 shares in the last quarter. Finally, Apollon Wealth Management LLC increased its position in shares of Inspire Medical Systems by 5.6% during the first quarter. Apollon Wealth Management LLC now owns 3,997 shares of the company’s stock worth $206,000 after acquiring an additional 212 shares during the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on the company. Royal Bank Of Canada cut Inspire Medical Systems from a “sector perform” rating to a “buy” rating in a research note on Monday, June 15th. Freedom Capital upgraded Inspire Medical Systems to a “strong-buy” rating in a research note on Tuesday. Zacks Research downgraded Inspire Medical Systems from a “hold” rating to a “strong sell” rating in a report on Wednesday, May 13th. Robert W. Baird cut their target price on Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Finally, Summit Redstone set a $39.00 target price on Inspire Medical Systems in a research note on Friday, May 22nd. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, thirteen have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $81.05.

Inspire Medical Systems Stock Performance

Shares of Inspire Medical Systems stock opened at $46.95 on Friday. Inspire Medical Systems, Inc. has a 1 year low of $38.91 and a 1 year high of $147.03. The firm’s 50-day simple moving average is $44.57 and its 200-day simple moving average is $62.43. The firm has a market cap of $1.35 billion, a PE ratio of 10.46, a price-to-earnings-growth ratio of 4.75 and a beta of 0.71.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings results on Monday, May 4th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.38. The business had revenue of $204.58 million during the quarter, compared to the consensus estimate of $200.04 million. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period last year, the firm earned $0.10 earnings per share. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. On average, equities analysts predict that Inspire Medical Systems, Inc. will post 0.93 earnings per share for the current year.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.